US.MDT · Medtronic

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.8,
      "details": {
        "atrPct": 2.67944290976059,
        "turnoverUsdM": 1134.4402046399998,
        "liquidityPoints": 0.8,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.8,
    "stopLevels": {
      "symbol": "US.MDT",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 82.2242,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 3,
        "macd_score": 3,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.7,
      "stop_loss_percent": 5.4,
      "take_profit_price": 94.9035,
      "target_multiplier": 2.2,
      "technical_strength": 2.35,
      "take_profit_percent": 9.2
    },
    "positionPoints": 1.8,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.7167747755487774,
    "stopLossPercent": 5.35888581952118,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 88,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 60,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 28
  },
  "market": {
    "ma20": 82.4865,
    "ma50": 80.2802,
    "close": 86.88,
    "prevClose": 84.22,
    "avgVolume20": 7633783,
    "volumeRatio": 1.71,
    "changePercent": 3.16
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 28,
    "details": {
      "ret_5d": 0.05500910746812382,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 28,
      "vcp_bonus": 0,
      "vol_ratio": 1.7619698088052929,
      "ret_points": 8,
      "vol_points": 6,
      "range_ratio": 1.2983593732773262,
      "volat_points": 2,
      "day_range_pct": 0.031998158379373864,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 8,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 1,
      "first_breakout_20d": true,
      "return_window_days": 5,
      "first_breakout_bonus": 2,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 88,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.6,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 72,
        "contribution": 3.6
      },
      {
        "raw": 13.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 66,
        "contribution": 13.2
      },
      {
        "raw": 6.4,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 42.67,
        "contribution": 6.4
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.4,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 74,
        "contribution": 7.4
      },
      {
        "raw": 24.4,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 81.33,
        "contribution": 24.4
      },
      {
        "raw": 3,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 30,
        "contribution": 3
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 60,
    "details": [
      "基本面分析總分: 3.6/5分",
      "資金流分析總分: 13.2/20分",
      "市場環境分析總分: 6.4/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.4/10分",
      "技術信號分析總分: 24.4/30分",
      "情緒分析: 3/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.6,
      "資金流": 13.2,
      "市場環境": 6.4,
      "情緒分析": 3,
      "技術信號": 24.4,
      "風險管理": 7.4
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "良好",
        "items": {
          "pbPoints": 0.5,
          "pePoints": 0.4,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.4,
          "marginPoints": 0.4,
          "turnoverUsdM": 1134.4402046399998,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0.5,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "一般",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 3.2,
          "obvPoints": 3.2,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.MDT",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 1.8,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 18.67
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 708.0634979000001,
                "ma50": 716.7494019999999,
                "name": "QQQ",
                "close": 675.48999,
                "points": 0.4
              },
              "spy": {
                "ma20": 746.6510067000002,
                "ma50": 744.8574021799999,
                "name": "SPY",
                "close": 740.85999,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.67944290976059,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 1.8,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 3,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 1,
              "sentimentScoreRaw": 0.3
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141040706,
                "url": "https://finnhub.io/api/news?id=884f19b4e86c5f026b215a61a3daca1d5c2d2bd50fc36f3770f98f6ee1386695",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (MDT) is in focus after a voluntary Class II recall of its DLP One-Piece Pediatric Arterial Cannula, following two complaints about loose foreign material containing trace levels of blood. See our latest analysis for Medtronic. Despite the recall headlines, Medtronic’s recent 30-day share price return of 4.00% and 90-day share price return of 2.83% sit against a year-to-date share price decline of 12.32%. The 3-year total shareholder return of 5.91% contrasts with a 5-year total...",
                "category": "company",
                "datetime": 1785222570,
                "headline": "Is Medtronic (MDT) Fairly Valued After Its Pediatric Cannula Recall?"
              },
              {
                "id": 141040707,
                "url": "https://finnhub.io/api/news?id=99448b1eb689f9fb453eea7e1e3023961a969f144de175499acfbbc37c1ddb76",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (NYSE:MDT) has completed its US$650m acquisition of SPR Therapeutics. The company formally launched the ViaVerte system at ASPN 2026, expanding its pain therapy portfolio. The deal adds a non opioid pain management platform to Medtronic’s existing medical device offerings. Medtronic is known for its broad medical device portfolio across cardiology, neurology and surgical care. With the SPR Therapeutics deal and ViaVerte launch, the company is putting more weight behind...",
                "category": "company",
                "datetime": 1785218985,
                "headline": "Medtronic (MDT) Completes $650 Million SPR Deal And Launches ViaVerte"
              },
              {
                "id": 141039668,
                "url": "https://finnhub.io/api/news?id=0361353319a8870517fac2bff2c0a12d20fe65d225e88a60290737f2e4abd8ca",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic stock is coming off a 5 year period where the share price has fallen about 25%, yet current checks suggest the shares sit close to their intrinsic value on a Discounted Cash Flow (DCF) basis and screen as undervalued on earnings multiples. That mix, alongside fresh moves in AI assisted surgery and pain management, leaves investors weighing whether the current price around US$84.22 offers enough compensation for the risks. Over 5 years the share price has declined about 25%, which...",
                "category": "company",
                "datetime": 1785204552,
                "headline": "Medtronic (MDT) Stock May Be Fairly Valued As Shares Sit Near A 5 Year Low"
              },
              {
                "id": 141038209,
                "url": "https://finnhub.io/api/news?id=2bb8c4fb1b536fd9f2a337bc87b71cce228aca8bd9d507577176072a1bca904e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (MDT) closed at $84.22 in the latest trading session, marking a +1.21% move from the prior day.",
                "category": "company",
                "datetime": 1785189003,
                "headline": "Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know"
              },
              {
                "id": 141015190,
                "url": "https://finnhub.io/api/news?id=a1740af6ee5bb16e8078372181f62d0df745b3c8a1307681af8f6b4ea8cf6b6d",
                "image": "https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp",
                "source": "ChartMill",
                "related": "MDT",
                "summary": "Medtronic (MDT) appears in a Decent Value screen: cheap valuation, strong profitability, and improving growth outlook for value investors.",
                "category": "company",
                "datetime": 1784974259,
                "headline": "Medtronic (NYSE:MDT): A Value Stock with a Discounted Valuation and Accelerating Growth"
              },
              {
                "id": 140980354,
                "url": "https://finnhub.io/api/news?id=df9f1d697f207b91ea14cd0afee7c798e748350c7c4c4e6d36f73f53f54c76e7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (NYSE:MDT) has introduced Touch Surgery Aide, a next generation real-time AI platform designed for operating rooms. The platform supports AI driven surgical decision assistance for robotic assisted procedures. Its first live AI application, Instrument Exit Point (IEP), has received FDA clearance, signaling clinical and regulatory progress. Medtronic enters this launch with its stock at $82.35 and mixed recent performance. The shares are up 3.8% over the past week and 3.8% over the...",
                "category": "company",
                "datetime": 1784711461,
                "headline": "Medtronic (MDT) Unveils Touch Surgery Aide For Real Time AI In Operating Rooms"
              },
              {
                "id": 140977726,
                "url": "https://finnhub.io/api/news?id=9651a5589cca792b3ba10766232e4946c027a81dd101789a543466a9be76cae8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (MDT) reached $82.35 at the closing of the latest trading day, reflecting a -1.13% change compared to its last close.",
                "category": "company",
                "datetime": 1784670605,
                "headline": "Medtronic (MDT) Stock Declines While Market Improves: Some Information for Investors"
              },
              {
                "id": 140930165,
                "url": "https://finnhub.io/api/news?id=6fe459ad1a31c2103ab611f978bfeb25d7aefe2ce166d8f775aa1d8a8675b91d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (NYSE:MDT) has completed its acquisition of SPR Therapeutics. The deal adds a minimally invasive, non opioid treatment option for chronic and acute pain to Medtronic's pain therapy portfolio. For investors watching Medtronic, this move expands the company's presence in pain care beyond its existing device lineup. SPR Therapeutics focuses on peripheral nerve stimulation, a therapy that fits into a broader push across healthcare to reduce reliance on opioid medications for pain...",
                "category": "company",
                "datetime": 1784279582,
                "headline": "Medtronic (MDT) Completes SPR Therapeutics Deal To Expand Non Opioid Pain Care"
              }
            ],
            "raw_source": [
              {
                "id": 141047303,
                "url": "https://finnhub.io/api/news?id=556426890a3fac26e5447912eb362cc02010df281b0dcb32f90c4409a7a36c9e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Johnson & Johnson stock's oncology engine and its steady guidance raises were on the record quarters before the price moved.",
                "category": "company",
                "datetime": 1785271965,
                "headline": "What Johnson & Johnson Stock Told You Before It Surged"
              },
              {
                "id": 141046228,
                "url": "https://finnhub.io/api/news?id=366bb3ca8848ba5152308566799255dd9d7dc151bab93b311925e61a56141cda",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Digital Transformation in Healthcare Market size & share revenue was valued at approximately USD 72.3 Billion in 2025 and is expected to reach USD 81.7 Billion in 2026 and is expected to reach around USD 270.9 Billion by 2035, at a CAGR of 14.13% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Oracle Hea",
                "category": "company",
                "datetime": 1785267000,
                "headline": "Global Digital Transformation in Healthcare Market Size/Share Worth USD 270.9 Billion by 2035 at a 14.13% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)"
              },
              {
                "id": 141042348,
                "url": "https://finnhub.io/api/news?id=56f2f285ff59a3a37ef0ce4aefbadc33ee3bcdb7f56f7c7e94741a06e3cf8529",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Intuitive Surgical (NASDAQ:ISRG) trades at $356.83, while the average Wall Street price target sits at $484.40. That leaves roughly a 36% gap between current price and Street consensus. Intuitive builds the da Vinci robotic surgery platform and the Ion lung biopsy system, dominating soft tissue surgical robotics. Wall Street has debated whether that moat holds ... Intuitive Surgical Fell 37% to $355 With This Wall Street Pro Is Calling for $685",
                "category": "company",
                "datetime": 1785246435,
                "headline": "Intuitive Surgical Fell 37% to $355 With This Wall Street Pro Is Calling for $685"
              },
              {
                "id": 141043715,
                "url": "https://finnhub.io/api/news?id=c1ea1eb6a2951f004125dc530ce0cb2e9c935f6d2ff11d03b16788839719982a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "ABT is expanding across diabetes care, oncology diagnostics and heart devices, with new launches and acquisitions creating multiple growth paths to watch.",
                "category": "company",
                "datetime": 1785245340,
                "headline": "Abbott Rides Key Diabetes, Oncology and Heart Care Innovation Trends"
              },
              {
                "id": 141042564,
                "url": "https://finnhub.io/api/news?id=5ff9fcd840a0108c3e0a257968ab637b575a91a691813218bd86fb06c7474223",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "TXN posted strong Q2 2026 results as AI-driven demand, expanding margins and upbeat guidance strengthen its momentum outlook.",
                "category": "company",
                "datetime": 1785240060,
                "headline": "Buy Texas Instruments as a Momentum Play After Solid Q2 2026 Earnings"
              },
              {
                "id": 141041757,
                "url": "https://finnhub.io/api/news?id=e608a003141f5e728800fd2bcdd8587566b862645fcbc91a95de09a83cfd0975",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Cloud-based AI algorithm supports implantable cardiac monitors from all major manufacturers, reducing false-positive alerts by up to 76% while maintaining high sensitivity for true events CAMBRIDGE, Mass., July 28, 2026 (GLOBE NEWSWIRE) -- Implicity, a leader in remote patient monitoring and cardiac data management solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its next-generation ILR ECG Analyzer, marking Implicity's third FDA cleara",
                "category": "company",
                "datetime": 1785239100,
                "headline": "Implicity’s Next-Generation ILR ECG Analyzer Earns FDA Clearance"
              },
              {
                "id": 141044506,
                "url": "https://finnhub.io/api/news?id=b5212a9cffc22f69af429a94a00b73834871dd744452ce9c9e0c1171347e5069",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/28/Healthcare-stocks.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MDT",
                "summary": "In times of market turbulence, dividend-yielding stocks are popular for investors. Check out analyst ratings for high-yielding stocks and recent news on Bristol-Myers Squibb, GSK, and Medtronic PLC on Benzinga's Analyst Stock Ratings page.Investors turn to dividend-yielding stocks in turbulent markets. Check out analyst ratings and news for high-yielding stocks on Benzinga's Analyst Stock Ratings page.",
                "category": "company",
                "datetime": 1785224299,
                "headline": "Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields"
              },
              {
                "id": 141040706,
                "url": "https://finnhub.io/api/news?id=884f19b4e86c5f026b215a61a3daca1d5c2d2bd50fc36f3770f98f6ee1386695",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (MDT) is in focus after a voluntary Class II recall of its DLP One-Piece Pediatric Arterial Cannula, following two complaints about loose foreign material containing trace levels of blood. See our latest analysis for Medtronic. Despite the recall headlines, Medtronic’s recent 30-day share price return of 4.00% and 90-day share price return of 2.83% sit against a year-to-date share price decline of 12.32%. The 3-year total shareholder return of 5.91% contrasts with a 5-year total...",
                "category": "company",
                "datetime": 1785222570,
                "headline": "Is Medtronic (MDT) Fairly Valued After Its Pediatric Cannula Recall?"
              },
              {
                "id": 141040707,
                "url": "https://finnhub.io/api/news?id=99448b1eb689f9fb453eea7e1e3023961a969f144de175499acfbbc37c1ddb76",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (NYSE:MDT) has completed its US$650m acquisition of SPR Therapeutics. The company formally launched the ViaVerte system at ASPN 2026, expanding its pain therapy portfolio. The deal adds a non opioid pain management platform to Medtronic’s existing medical device offerings. Medtronic is known for its broad medical device portfolio across cardiology, neurology and surgical care. With the SPR Therapeutics deal and ViaVerte launch, the company is putting more weight behind...",
                "category": "company",
                "datetime": 1785218985,
                "headline": "Medtronic (MDT) Completes $650 Million SPR Deal And Launches ViaVerte"
              },
              {
                "id": 141039668,
                "url": "https://finnhub.io/api/news?id=0361353319a8870517fac2bff2c0a12d20fe65d225e88a60290737f2e4abd8ca",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic stock is coming off a 5 year period where the share price has fallen about 25%, yet current checks suggest the shares sit close to their intrinsic value on a Discounted Cash Flow (DCF) basis and screen as undervalued on earnings multiples. That mix, alongside fresh moves in AI assisted surgery and pain management, leaves investors weighing whether the current price around US$84.22 offers enough compensation for the risks. Over 5 years the share price has declined about 25%, which...",
                "category": "company",
                "datetime": 1785204552,
                "headline": "Medtronic (MDT) Stock May Be Fairly Valued As Shares Sit Near A 5 Year Low"
              },
              {
                "id": 141038209,
                "url": "https://finnhub.io/api/news?id=2bb8c4fb1b536fd9f2a337bc87b71cce228aca8bd9d507577176072a1bca904e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (MDT) closed at $84.22 in the latest trading session, marking a +1.21% move from the prior day.",
                "category": "company",
                "datetime": 1785189003,
                "headline": "Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know"
              },
              {
                "id": 141035129,
                "url": "https://finnhub.io/api/news?id=c92ef4a473af545abf93085c0feb833d345113b7ee6e12a65912c65c41f0d0ff",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "J&J's MedTech growth slowed down in Q2 as Cardiovascular lagged, but new product launches and stronger Vision, Surgery and Orthopedics may lift H2 sales.",
                "category": "company",
                "datetime": 1785167220,
                "headline": "J&J's MedTech Performance Slows in Q2: Will Sales Improve in H2?"
              },
              {
                "id": 141033957,
                "url": "https://finnhub.io/api/news?id=f9c77f2c7a2b30fa8a6e2c19700b09a28d1482789e3ac5a2c0c0cc32cff09d93",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "A steadily shrinking share count and a giant float owed to suppliers are handing owners a bigger slice of the drug distributor each year, even as drug-pricing worries hang over the stock.",
                "category": "company",
                "datetime": 1785160469,
                "headline": "The Buyback Machine Hiding Behind Cardinal Health's Thin Margins"
              },
              {
                "id": 141033911,
                "url": "https://finnhub.io/api/news?id=3609c866b6c1c8cb9e463baa69526262f4a9897a86ea509014ba2e333ed00030",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "ABT's earnings beat and higher profit outlook strengthen its case, but can growth in devices and diagnostics overcome valuation and acquisition concerns?",
                "category": "company",
                "datetime": 1785156060,
                "headline": "Is Abbott Stock Attractive After Its Earnings and Guidance Update?"
              },
              {
                "id": 141032243,
                "url": "https://finnhub.io/api/news?id=2dabf0acd258c992ef894f86a9c9a077827217cddc613923fdb41d1a5288f872",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic formally launched ViaVerte at ASPN 2026, with its $650m acquisition of SPR Therapeutics completing at the meeting’s outset on 16 July.",
                "category": "company",
                "datetime": 1785150951,
                "headline": "Medtronic continues assembly of industry’s “broadest” pain therapy portfolio"
              },
              {
                "id": 141031076,
                "url": "https://finnhub.io/api/news?id=62173fbda2301693a92f3d5da56390b4ea3db8e08c290385b475eabf6e1d5a7b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The company that used to reassure you with its sheer breadth now leads with a push to dominate oncology, and a holder who bought a diversified compounder should notice the bet has changed shape.",
                "category": "company",
                "datetime": 1785135053,
                "headline": "Johnson & Johnson Now Leads Its Pitch With An Oncology Bet"
              },
              {
                "id": 141016864,
                "url": "https://finnhub.io/api/news?id=02a7054929fccd13b94135fcc42ef9eaf195056dd9ae3898a266d92a88bdf526",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Management's plain health care label has slipped out of the lead, and the business now on a separation clock is the one that finally started working.",
                "category": "company",
                "datetime": 1784989802,
                "headline": "Johnson & Johnson Is Becoming A Narrower Company Than You Bought"
              },
              {
                "id": 141015190,
                "url": "https://finnhub.io/api/news?id=a1740af6ee5bb16e8078372181f62d0df745b3c8a1307681af8f6b4ea8cf6b6d",
                "image": "https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp",
                "source": "ChartMill",
                "related": "MDT",
                "summary": "Medtronic (MDT) appears in a Decent Value screen: cheap valuation, strong profitability, and improving growth outlook for value investors.",
                "category": "company",
                "datetime": 1784974259,
                "headline": "Medtronic (NYSE:MDT): A Value Stock with a Discounted Valuation and Accelerating Growth"
              },
              {
                "id": 141005276,
                "url": "https://finnhub.io/api/news?id=fce891feb90878c9b568365dc8ab8155bd45866a90ca9d2b3a5d6fc1f72863eb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The robotic surgery leader's shares have pulled back, forcing investors to weigh a solid recovery record against new questions in its most important market.",
                "category": "company",
                "datetime": 1784897252,
                "headline": "Intuitive Surgical Stock Is On Sale, But Is The Growth Story Changing?"
              },
              {
                "id": 141017280,
                "url": "https://finnhub.io/api/news?id=76d2787cc2237b397d2f26adc0684909ea937123a4b2b20124117fe4fa5e2b68",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/24/24-7-2026-111735-thebambooworks-com.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MDT",
                "summary": "The medical robot maker expects to report a profit of 28 million yuan to 40 million yuan for the first half of 2026, reversing years of losses\n\n\n\n\n\n\n\nimage credit: Bamboo Works\n\n\n\nKey Takeaways:\n\n\n\n\nMicroPort MedBot",
                "category": "company",
                "datetime": 1784897088,
                "headline": "MicroPort MedBot To Report First-Ever Profit On Booming Exports"
              },
              {
                "id": 141005373,
                "url": "https://finnhub.io/api/news?id=b36b031e7ee377bc4138167b006d1828b02fd77c1e500f55b43a05f249614da2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Device makers with cash flow yields of 5% to 6% now trade at a 20% to 30% discount to the S&P 500 index.",
                "category": "company",
                "datetime": 1784895900,
                "headline": "6 Medical-Device Stocks to Buy After a Massive Selloff"
              },
              {
                "id": 141003245,
                "url": "https://finnhub.io/api/news?id=2ebd8eda6820cc2c6f0a825f7bed40d44a97ae7a597344157a7a0eb81e98b72d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Device makers with cash flow yields of 5% to 6% now trade at a 20% to 30% discount to the S&P 500 index.",
                "category": "company",
                "datetime": 1784871000,
                "headline": "Medical-Device Stocks Are in the Bargain Bin. 6 to Buy."
              },
              {
                "id": 140997814,
                "url": "https://finnhub.io/api/news?id=24d2e0fc54cab935e274a3e8fcb16db266c3a84f202471884f91fe10684e6523",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": ": Medtronic is set to report Q1 earnings, with analysts expecting high single-digit year-over-year EPS growth.",
                "category": "company",
                "datetime": 1784808273,
                "headline": "Medtronic Earnings Preview: What to Expect"
              },
              {
                "id": 140991917,
                "url": "https://finnhub.io/api/news?id=7ab192dfbf41ef76ac4294c5809430ed4818de2a6746036969d6d7104a33c13e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Implantable Cardiac Fluorine-Free Resins Market size & share revenue was valued at approximately USD 1.52 Billion in 2025 and is expected to reach USD 1.67 Billion in 2026 and is expected to reach around USD 4.26 Billion by 2035, at a CAGR of 10.8% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Covestro",
                "category": "company",
                "datetime": 1784795400,
                "headline": "[Latest] Global Implantable Cardiac Fluorine-Free Resins Market Size/Share Worth USD 4.26 Billion by 2035 at a 10.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate,SWOT Analysis)"
              },
              {
                "id": 140984722,
                "url": "https://finnhub.io/api/news?id=eb4380e4b81ff41df4f41f4d09a834efdf3a51fc5ecc7ebde526712ba4b692b7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Intuitive Surgical's growth rests on da Vinci 5, Ion, SP and digital tools as recurring revenue rises and procedure risks persist.",
                "category": "company",
                "datetime": 1784736300,
                "headline": "ISRG Growth Story Hinges on Da Vinci 5, Ion and Recurring Revenue"
              },
              {
                "id": 140984723,
                "url": "https://finnhub.io/api/news?id=b43dd450ad337f594f3885cf44a2dfe69b42d47cc6c24474b47251767859f188",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "ISRG's growth is fueled by robotic surgery, Ion lung biopsy and AI tools, while tariffs, product mix and softer demand pressure margins.",
                "category": "company",
                "datetime": 1784736240,
                "headline": "ISRG Trends Point to AI, Lung Biopsy Growth and Margin Pressure"
              },
              {
                "id": 140984724,
                "url": "https://finnhub.io/api/news?id=b815e8f186230069c844603013fcb9e7af4852d0d473a0021673777909f3f8df",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "ISRG's strong procedure growth, recurring revenue and cash position support its case, but tariffs, mix shifts and placement risks cloud the outlook.",
                "category": "company",
                "datetime": 1784736180,
                "headline": "Is ISRG Stock Worth Buying as Growth Stays Strong but Risks Rise"
              },
              {
                "id": 140983576,
                "url": "https://finnhub.io/api/news?id=cc56e6ed0f66a3ccedc5e3999eea4c7c34fced4b564f2e0639177abb9b833498",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1664824574/image_1664824574.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MDT",
                "summary": "Orchestra BioMed nears pivotal trial readouts for AVIM Therapy & Virtue SAB, backed by Medtronic/Terumo. Click to see catalysts, valuation & upside.",
                "category": "company",
                "datetime": 1784722005,
                "headline": "Orchestra BioMed: Nearing The First Of Two Pivotal Readouts"
              },
              {
                "id": 140983039,
                "url": "https://finnhub.io/api/news?id=3af468cbae481110ca71e4daaf0b3848b3cb86aca78ef879769dc79ed3241107",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Johnson & Johnson said on Wednesday the U.S. Food and Drug Administration had granted marketing authorization for its robotic surgery ‌device, as the healthcare conglomerate enters the soft-tissue robotic surgery market.  The decision ‌marks a key step for J&J's medtech business that had been seeking to compete in the robotic-assisted ​surgery market, currently dominated by Intuitive Surgical's da Vinci system.  Medtronic's Hugo robot was also approved last year.",
                "category": "company",
                "datetime": 1784719310,
                "headline": "J&J enters US robotic surgery market after device gets marketing authorization"
              },
              {
                "id": 140984726,
                "url": "https://finnhub.io/api/news?id=b007f8436b6a97262a650356dc317c7c77e8620d53a9fd7822da3e4e79f99ca5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "While Johnson & Johnson will go head to head with Intuitive in the U.S., analysts questioned whether its robotic surgery system will take meaningful share from the market leader.",
                "category": "company",
                "datetime": 1784717586,
                "headline": "J&J gets FDA authorization for Ottava robot, teeing up competition with Intuitive"
              },
              {
                "id": 140980354,
                "url": "https://finnhub.io/api/news?id=df9f1d697f207b91ea14cd0afee7c798e748350c7c4c4e6d36f73f53f54c76e7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (NYSE:MDT) has introduced Touch Surgery Aide, a next generation real-time AI platform designed for operating rooms. The platform supports AI driven surgical decision assistance for robotic assisted procedures. Its first live AI application, Instrument Exit Point (IEP), has received FDA clearance, signaling clinical and regulatory progress. Medtronic enters this launch with its stock at $82.35 and mixed recent performance. The shares are up 3.8% over the past week and 3.8% over the...",
                "category": "company",
                "datetime": 1784711461,
                "headline": "Medtronic (MDT) Unveils Touch Surgery Aide For Real Time AI In Operating Rooms"
              },
              {
                "id": 140977726,
                "url": "https://finnhub.io/api/news?id=9651a5589cca792b3ba10766232e4946c027a81dd101789a543466a9be76cae8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (MDT) reached $82.35 at the closing of the latest trading day, reflecting a -1.13% change compared to its last close.",
                "category": "company",
                "datetime": 1784670605,
                "headline": "Medtronic (MDT) Stock Declines While Market Improves: Some Information for Investors"
              },
              {
                "id": 140974912,
                "url": "https://finnhub.io/api/news?id=bbdead80568b813174817288369cedcdbc1558cbe69a3fa5d808987e69a9b82d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The market is offering a steep discount on this medical device maker, but the price tag comes with a story about slowing growth. Here’s how to read it.",
                "category": "company",
                "datetime": 1784660157,
                "headline": "Why BSX Stock Hands You So Much Cash Right Now"
              },
              {
                "id": 140974913,
                "url": "https://finnhub.io/api/news?id=aa203e7f28d79433427fb12950820e559672ed5b69c0e2a20f702bef68a97fcc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "At $353, Intuitive Surgical (ISRG) is being priced to deliver 14.1% revenue growth annually for the next 4 years simply to defend today's 42.1x multiple. That sits below the 21% the business is currently growing at, which is the unusual part. The multiple has already priced in a slowdown that has not yet appeared.",
                "category": "company",
                "datetime": 1784659383,
                "headline": "ISRG Stock: The Math Hidden In Its Price"
              },
              {
                "id": 140969413,
                "url": "https://finnhub.io/api/news?id=961a0334dc44ccfb611ea4323ba249e691e72e4e5e2e277dae75441a1b2d85ac",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (NYSE: MDT), a global leader in healthcare technology, is presenting an early look at its next-generation compute platform for the operating room. Touch Surgery™ Aide — an AI-native surgical computing platform that powers the Touch Surgery™ ecosystem — enables real-time artificial intelligence during procedures. Touch Surgery™ Aide will be shared at the Society of Robotic Surgery (SRS) 2026 Annual Meeting in Florida, July 23-26.",
                "category": "company",
                "datetime": 1784631600,
                "headline": "A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026"
              },
              {
                "id": 140963421,
                "url": "https://finnhub.io/api/news?id=6ea0dd033658292f48582a592a40caa31066d357172a543dd20d199c2861cc74",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "You can be forgiven for doing a double-take on Intuitive Surgical (ISRG) on Friday. The company posted second-quarter revenue of $2.89 billion, up 19% from a year ago and comfortably ahead of Wall Street estimates. Yet the stock ended the day down 14.1%, closing at a new 52-week low.",
                "category": "company",
                "datetime": 1784574905,
                "headline": "The Robot Maker's Paradox"
              },
              {
                "id": 140963403,
                "url": "https://finnhub.io/api/news?id=f4884d142c8fe4723c200af3df0c71c73b1c873e2c314a7447d92ad950c86ede",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The healthcare giant's pharma division is booming, but analysts on its latest call wanted to know if that's enough to cover for a sudden slowdown in MedTech.",
                "category": "company",
                "datetime": 1784573756,
                "headline": "Reading Between The Lines Of JNJ Stock's Latest Call"
              },
              {
                "id": 140963423,
                "url": "https://finnhub.io/api/news?id=26047126ae59bd8c4eb72c217ec847dd194744894cd020aa98db1bbb6da3a19e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The surgical robotics giant beat estimates, but a moderation in its core US market has investors questioning the whole story.",
                "category": "company",
                "datetime": 1784571665,
                "headline": "What's More Important For Intuitive Surgical: Today's Robots Or Tomorrow's Growth?"
              },
              {
                "id": 140962214,
                "url": "https://finnhub.io/api/news?id=5fa01c47ee66f755ff66c19d211444017289dcf37faf29d20577f11abcb01105",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Leading CIOs and CISOs honored for leadership, innovation, and business impact. MINNEAPOLIS, July 20, 2026 (GLOBE NEWSWIRE) -- The 2026 Minnesota ORBIE Awards honored leading chief information officers (CIOs) and chief information security officers (CISOs) from Minnesota Twins, Medtronic, Sanford Health, Cirrus Aircraft, City of Saint Paul, Data Recognition Corporation, Transamerica and Medica for their exceptional leadership. Hosted by MinnesotaCIO and MinnesotaCISO, two of over 50 Inspire Lead",
                "category": "company",
                "datetime": 1784567700,
                "headline": "2026 Minnesota ORBIE Awards Recognize Minnesota’s Top Technology and Security Executives"
              },
              {
                "id": 140958770,
                "url": "https://finnhub.io/api/news?id=b059ccc9cc5ce8a6c9282abf2ebd56428803781d09b0c80c6403e7fb908459f9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, September 1, 2026, for its first quarter of fiscal year 2027, which ends on Friday, July 31, 2026.",
                "category": "company",
                "datetime": 1784545200,
                "headline": "Medtronic to announce financial results for its first quarter of fiscal year 2027"
              },
              {
                "id": 140951754,
                "url": "https://finnhub.io/api/news?id=6ba6159069d25ba45726b5c1d6ff6db30fd98807f5de1cad5c47a5f9d5cff570",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Intuitive Surgical shares fell about 10% after Q2 2026 revenue rose 19% but guidance for da Vinci procedure growth wasn't raised, pushing ISRG below its 200-week moving average.",
                "category": "company",
                "datetime": 1784376900,
                "headline": "Why Intuitive Surgical’s Strong Quarter Still Spooked Investors"
              },
              {
                "id": 140939163,
                "url": "https://finnhub.io/api/news?id=2b7e563ff687d8cc979d3783bccd33f2bf9feb60d528dbd963b372e93e4735fb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The healthcare giant's stock jump was about more than an earnings beat, offering proof of a growth story broader and more resilient than you thought.",
                "category": "company",
                "datetime": 1784328964,
                "headline": "Abbott Just Showed Its Growth Engine Has More Than One Cylinder"
              },
              {
                "id": 140931564,
                "url": "https://finnhub.io/api/news?id=c1f3439f3f31bb5e63491154cf43bcb3dc1f5d6f47086643b3ecba50b2f29e50",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Intuitive Surgical stock falls sharply after earnings, but this analyst believes investors are missing part of the picture.",
                "category": "company",
                "datetime": 1784301540,
                "headline": "Why This Surgical Robot Stock Is Still a Buy During Its Worst Day in 4 Years"
              },
              {
                "id": 140932973,
                "url": "https://finnhub.io/api/news?id=0504e442cf7f265bb43b0e44d54c0386af3ed0aa7fd4f592d362e90177bbdfa3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "JNJ beats Q2 estimates and raises 2026 guidance, but shares fall as MedTech misses expectations. Find out what weighed on the unit and what's next.",
                "category": "company",
                "datetime": 1784298660,
                "headline": "J&J Stock Falls Despite Strong Q2 Beat & Higher 2026 View: Here's Why"
              },
              {
                "id": 140931563,
                "url": "https://finnhub.io/api/news?id=9a8cdb541c3ef9be788480458508c8b7afe3ea54b0f0964b1a39fcf2f3561dab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "This healthcare giant is forecasting a significant acceleration, but you are being asked to look past a slowdown in its biggest growth engine and other execution hurdles.",
                "category": "company",
                "datetime": 1784290654,
                "headline": "Can Abbott Stock Deliver on Its Second-Half Growth Promise?"
              },
              {
                "id": 140934573,
                "url": "https://finnhub.io/api/news?id=ff4636b7146dfbd125893355575681ad2790e436aa27f7e2e640993f0f0632fc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic bought the pain company to expand in neuromodulation, one of its areas of strategic focus and investment.",
                "category": "company",
                "datetime": 1784289240,
                "headline": "Medtronic completes SPR Therapeutics acquisition"
              },
              {
                "id": 140930838,
                "url": "https://finnhub.io/api/news?id=1a135d3985c03c15f27f2817229afbb531c278155028de7596572fb52e06bd0c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The new capital will enable completion of the multi-centre investigational device exemption trial, TURBO.",
                "category": "company",
                "datetime": 1784287380,
                "headline": "RapidPulse obtains funding for stroke aspiration system"
              },
              {
                "id": 140930165,
                "url": "https://finnhub.io/api/news?id=6fe459ad1a31c2103ab611f978bfeb25d7aefe2ce166d8f775aa1d8a8675b91d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (NYSE:MDT) has completed its acquisition of SPR Therapeutics. The deal adds a minimally invasive, non opioid treatment option for chronic and acute pain to Medtronic's pain therapy portfolio. For investors watching Medtronic, this move expands the company's presence in pain care beyond its existing device lineup. SPR Therapeutics focuses on peripheral nerve stimulation, a therapy that fits into a broader push across healthcare to reduce reliance on opioid medications for pain...",
                "category": "company",
                "datetime": 1784279582,
                "headline": "Medtronic (MDT) Completes SPR Therapeutics Deal To Expand Non Opioid Pain Care"
              },
              {
                "id": 140929130,
                "url": "https://finnhub.io/api/news?id=d17a9ca00e6827867f4faead149d1ad3a6253cf698cabd8781e37c5bdc1f82be",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic, a global leader in healthcare technology, and Apollo Hospitals today announced the inauguration of 'ICU of the Future' an 11-bed, state-of-the-art Intensive Care Unit (ICU) at Apollo Hospitals, Jubilee Hills. The new facility will be fully integrated with Medtronic's advanced Acute Care & Monitoring (ACM) technologies and solutions, marking a significant milestone in collaborative healthcare innovation.",
                "category": "company",
                "datetime": 1784262600,
                "headline": "Medtronic and Apollo Hospitals Announce Strategic Partnership to Establish State-of-the-Art Advanced ICU in Hyderabad"
              },
              {
                "id": 140928282,
                "url": "https://finnhub.io/api/news?id=59b1abf7332c16ef0dc2c636d71381833f2aed80f0c8396e7368a03e0d790e77",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "In May 2026, Medtronic voluntarily initiated a Class II recall of 590 Octopus 4 Tissue Stabilizer devices after discovering an assembly issue in the tubing configuration, with the US FDA now listing the action as an ongoing enforcement event affecting worldwide distribution. Around the same time, Medtronic’s fiscal Q3 2024 results exceeded earnings and revenue expectations, drawing attention to how the company balances quality-control challenges with operational and financial...",
                "category": "company",
                "datetime": 1784250696,
                "headline": "How Medtronic’s (MDT) Targeted Device Recall and Earnings Beat Have Changed Its Investment Story"
              },
              {
                "id": 140920976,
                "url": "https://finnhub.io/api/news?id=76bc23d4d790ded7e25ac854371641c9f43064d0b6f2a5978ce3830dc769912b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Abbott’s (ABT) latest financial disclosure reveals a significant strategic evolution that market participants often overlook amidst the focus on quarterly beats. The company is actively executing a structural pivot, shifting its capital allocation and growth dependency away from the volatile Nutrition segment toward high-margin, innovation-led MedTech and specialized diagnostics.",
                "category": "company",
                "datetime": 1784210345,
                "headline": "Why Abbott Stock Is Reimagining Its Future"
              },
              {
                "id": 140919685,
                "url": "https://finnhub.io/api/news?id=8aaaa1ac492f93cd7e2c8a593e3ee9b65133645f1fcce9caf8568dc8cb52f96d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "While many investors focus on a slowdown in one business segment, they may be overlooking the remarkable growth occurring in another.",
                "category": "company",
                "datetime": 1784207994,
                "headline": "The Real Engine Behind Johnson & Johnson Stock's Next Climb"
              },
              {
                "id": 140919932,
                "url": "https://finnhub.io/api/news?id=d14539e7d0d93084fd85fd25537a4c9177a39c604c11304698740004010773da",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has completed its acquisition of SPR Therapeutics, Inc. (SPR), a privately held medical technology company and recognized leader in short-term, percutaneous peripheral nerve stimulation (PNS) therapies for chronic and acute pain management. The acquisition is valued at $650 million, consisting of an upfront cash payment.",
                "category": "company",
                "datetime": 1784206800,
                "headline": "Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain"
              },
              {
                "id": 140049019,
                "url": "https://finnhub.io/api/news?id=7a629db8b449d905f61c4ffdf1b6684b342fcc22ebf1c524d64b1d845debb6ed",
                "image": "",
                "source": "Benzinga",
                "related": "MDT",
                "summary": "",
                "category": "company",
                "datetime": 1784205329,
                "headline": "Carlsmed Announces Aprevo Bi-Lateral Posterior Lumbar Interbody Fusion Procedure"
              },
              {
                "id": 140919933,
                "url": "https://finnhub.io/api/news?id=a51bf2012721df69e5fb63d419bef55076b32cdcd5158fb046ab1523fb8070c2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Round includes participation from Medtronic and top healthcare investorsMIAMI, July 16, 2026 (GLOBE NEWSWIRE) -- RapidPulse, Inc., a medical technology company developing next-generation aspiration technology for the treatment of acute ischemic stroke, today announced the close of a $48 million Series B financing. The raise, which drew substantial investor interest, was co-led by Medtronic, TechWald Next S.p.A., and S3 Ventures. SBI Investment Company Ltd. and Florida Opportunity Fund also joine",
                "category": "company",
                "datetime": 1784205000,
                "headline": "RapidPulse Secures Oversubscribed $48M Series B Financing to Advance Clinical Development of Next-Generation Stroke Aspiration Technology"
              },
              {
                "id": 140912813,
                "url": "https://finnhub.io/api/news?id=af3b9436f23bb6328aa43e6b3e1faf8d7dd198364bfa6e28cf7cd911df9289f9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Intuitive Surgical's powerful growth is running headlong into some serious market challenges, and how management framed the collision tells you everything about the real risks.",
                "category": "company",
                "datetime": 1784140381,
                "headline": "The Open Questions On ISRG Stock"
              },
              {
                "id": 140911296,
                "url": "https://finnhub.io/api/news?id=aee602b293e01bdae62f2d6674938ab67845e74bf45b3536a1bd3aa55fdad064",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Johnson & Johnson stock dipped early Wednesday, though the healthcare giant beat second-quarter forecasts and raised its outlook.",
                "category": "company",
                "datetime": 1784134793,
                "headline": "J&J Slipped On Its Report; Why It Bodes Well For Intuitive, Abbott, Others"
              },
              {
                "id": 140906349,
                "url": "https://finnhub.io/api/news?id=860fb66b88fd759276769fb8a53b2780d4b74c57e4415a03d22a898482e4c8db",
                "image": "https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp",
                "source": "ChartMill",
                "related": "MDT",
                "summary": "Medtronic (NYSE:MDT) offers a strong 3.50% dividend yield, backed by top-tier profitability and a 10-year growth history, making it a standout pick for sustainable income investors.",
                "category": "company",
                "datetime": 1784103032,
                "headline": "Medtronic PLC (NYSE:MDT): A Top Dividend Stock for Quality and Income Investors"
              },
              {
                "id": 140901598,
                "url": "https://finnhub.io/api/news?id=1c30ec9fc5eaa65b249de9077cf426329d566c616ac5f9591f0e7f9ba8098349",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Intuitive Surgical stock tumbled Tuesday after HCA Healthcare trimmed its full-year earnings outlook, noting a drop in surgeries.",
                "category": "company",
                "datetime": 1784058057,
                "headline": "Why This Group Of Medical Giants, Including Intuitive Surgical, Just Took A Tumble"
              },
              {
                "id": 140901109,
                "url": "https://finnhub.io/api/news?id=deff9c90bb7e909239d4818d05eb00911aa88c16bd160a2315a273ea8e21cb70",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "MDT",
                "summary": "Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Tuesday as we examine the latest happenings in today's session.",
                "category": "company",
                "datetime": 1784055900,
                "headline": "Discover which S&P500 stocks are making waves on Tuesday."
              },
              {
                "id": 140901466,
                "url": "https://finnhub.io/api/news?id=3b28393a5831026f9ac3732237381ea888082eee864a93bb498cf961a423a22f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Here is a way to get paid a meaningful income now on your Intuitive Surgical shares, cash you keep no matter what, in exchange for capping your gains at a price above today's.",
                "category": "company",
                "datetime": 1784052407,
                "headline": "The Paid-To-Hold Play On ISRG Stock: A 12% Income"
              },
              {
                "id": 140898964,
                "url": "https://finnhub.io/api/news?id=76a3fb9d03f8bf894bf401ec3d9d7e7a7980e4769b9be8dd004e0986d25fa30d",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "MDT",
                "summary": "Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.",
                "category": "company",
                "datetime": 1784046901,
                "headline": "These S&P500 stocks are moving in today's session"
              },
              {
                "id": 140091407,
                "url": "https://finnhub.io/api/news?id=4f3bae5f1a4e13b081552f7770afdce76cba0f5763322ce7524be732ab5f910f",
                "image": "",
                "source": "Benzinga",
                "related": "MDT",
                "summary": "",
                "category": "company",
                "datetime": 1784034450,
                "headline": "Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation"
              },
              {
                "id": 140896860,
                "url": "https://finnhub.io/api/news?id=69cac81872a917b82ac0a4526f38f4b08928a2ae81ab419989126f3ac804ca95",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "This is a product-cycle year for Intuitive Surgical. The company's growth is fueled by hospitals and surgeons adopting its new da Vinci 5 and existing Ion robotic systems.",
                "category": "company",
                "datetime": 1784033543,
                "headline": "ISRG Stock: What Does Its Valuation Imply?"
              },
              {
                "id": 140898735,
                "url": "https://finnhub.io/api/news?id=5c19ba90558b63a8e3a7afa5519de014d199a61a22aab71804f621e6b3d1ed32",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/14/2026-To-Be-Far-Worse.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MDT",
                "summary": "Investors turn to dividend-yielding stocks during market turbulence. Benzinga's Analyst Stock Ratings page provides latest analyst takes on top stocks, sorted by accuracy. Ratings for three high-yielding health care stocks: VTRS, MDT, GSK. VTRS to report Q2 results on Aug.6, MDT recalls certain catheter system, GSK reports positive trial results. Benzinga Pro's newsfeed provides real-time alerts.",
                "category": "company",
                "datetime": 1784014208,
                "headline": "Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields"
              },
              {
                "id": 140894719,
                "url": "https://finnhub.io/api/news?id=0696d9a22b1282c2f8fcc200711ba2063bff307e55a7c7e92466a4ad93a64192",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Ian Wells, former Global Chief Financial Officer of HOYA Vision Care, appointed CFO, bringing multi-billion-dollar P&L leadership and capital-markets disciplineTom West, who led Intersect ENT to its $1.1 billion acquisition by Medtronic and Nalu Medical to its $600 million acquisition by Boston Scientific, joins as an Independent Board MemberAppointments build the financial and governance foundation for ViCentra’s next phase, following the recent scale-up of commercial manufacturing UTRECHT, The",
                "category": "company",
                "datetime": 1784014200,
                "headline": "ViCentra Appoints Ian Wells as Chief Financial Officer and Adds Medtech Veteran Tom West to its Board"
              },
              {
                "id": 140894196,
                "url": "https://finnhub.io/api/news?id=ce54dcd3213fe39a575ae9d8dfca8d8c3c8ab18a053b31d59baa95ee32ca2d22",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Blood Glucose Monitoring System Market size & share revenue was valued at approximately USD 16.8 Billion in 2025 and is expected to reach USD 18.3 Billion in 2026 and is expected to reach around USD 39.4 Billion by 2035, at a CAGR of 8.9% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Insulet Corporati",
                "category": "company",
                "datetime": 1784003400,
                "headline": "Global Blood Glucose Monitoring System Market Size to Reach USD 39.4 Billion by 2035 | Growing at 8.9% CAGR | Industry Trends, Market Share & Forecast – Custom Market Insights"
              },
              {
                "id": 140890735,
                "url": "https://finnhub.io/api/news?id=7009e2dda4d96c52e7d8fb57e4f9f0e47b2235c75db4148ec6061f98f4f790bd",
                "image": "",
                "source": "Benzinga",
                "related": "MDT",
                "summary": "https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/pulmonary-valve-catheter-delivery-system-recall-medtronic-removes-harmony-delivery-catheter-system",
                "category": "company",
                "datetime": 1783955562,
                "headline": "Reported Earlier: FDA Announces Medtronic Recalls Certain Harmony Delivery Catheter System"
              },
              {
                "id": 140885956,
                "url": "https://finnhub.io/api/news?id=087b5685a9462b95788424a1d6cfb48b2ecca25fbdba085caa948b1a96b5afbe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Intuitive Surgical (NASDAQ:ISRG) looks compelling ahead of its July 16 earnings report, and the setup rarely gets this clean for a category leader trading well below fair value. Shares sit at $413.58, down 26.71% YTD, while the 247 base-case target of $559.79 implies 35.35% upside. Wall Street sits higher still at $563.35, with 22 buy ... Intuitive Surgical Has +35% Upside: A Compelling Buy Story Before July 16",
                "category": "company",
                "datetime": 1783944022,
                "headline": "Intuitive Surgical Has +35% Upside: A Compelling Buy Story Before July 16"
              },
              {
                "id": 140885071,
                "url": "https://finnhub.io/api/news?id=71b31314daf117ab4b7a113eb37cfe524f5210f5754749ce4767d53f3ef0320c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Opportunities in the nerve repair biomaterials market include advancements in regenerative medicine, rising demand for minimally invasive procedures, and smart biomaterials integration. Growth is driven by increased traumatic brain injuries, aging populations, and regional expansion, especially in Asia-Pacific. Nerve Repair Biomaterials Market Nerve Repair Biomaterials Market Dublin, July 13, 2026 (GLOBE NEWSWIRE) -- The \"Nerve Repair Biomaterials Market Report 2026\" has been added to ResearchAn",
                "category": "company",
                "datetime": 1783942080,
                "headline": "Comprehensive Nerve Repair Biomaterials Market Report Published, Profiles Medtronic, Stryker, Boston Scientific, and 20 Other Key Players"
              },
              {
                "id": 140866977,
                "url": "https://finnhub.io/api/news?id=0d841222a702d83dfcafc636603343d7fe6996b525ab654670646640a50056d4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (MDT) reached $83.87 at the closing of the latest trading day, reflecting a +1.8% change compared to its last close.",
                "category": "company",
                "datetime": 1783720203,
                "headline": "Medtronic (MDT) Exceeds Market Returns: Some Facts to Consider"
              },
              {
                "id": 140866137,
                "url": "https://finnhub.io/api/news?id=3f13457ebf4a4219407fc1e247b73e139d9eff63c7d44cc4326643ba6b21d03b",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MDT",
                "summary": "A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the latest list here.",
                "category": "company",
                "datetime": 1783706132,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of July 12"
              },
              {
                "id": 140861684,
                "url": "https://finnhub.io/api/news?id=2d80c78d867e1b8c4361f0f878b8dcf7d65ca471b42d1cd018154a011edfcc86",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The company’s business grew at a healthy clip, yet its stock price went sideways and its valuation fell. Something has to give.",
                "category": "company",
                "datetime": 1783685317,
                "headline": "DXCM Grew. The Stock Did Not. Someone Is Wrong"
              },
              {
                "id": 140861555,
                "url": "https://finnhub.io/api/news?id=fe0097a1d1dc84c557427a69c3a73840d1ee31881d8fde66985a82b7b6aaa9cb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "This healthcare giant is on a serious run, but for investors arriving now, the question is whether the price of admission already includes the victory lap.",
                "category": "company",
                "datetime": 1783684953,
                "headline": "JNJ Stock Keeps Climbing. Should You Climb On?"
              },
              {
                "id": 140862482,
                "url": "https://finnhub.io/api/news?id=f79b38329fe8f4ff5178270d12df829719e6df5e056a8659eee81a0a2d2f2194",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2148729873/image_2148729873.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MDT",
                "summary": "Medtronic stock is a \"Buy\" given its premium-margin medtech, diversification, accelerated growth, and undervalued shares. Learn more.",
                "category": "company",
                "datetime": 1783682195,
                "headline": "Medtronic: Undervalued, And The Tailwinds Are Just Getting Started"
              },
              {
                "id": 140862203,
                "url": "https://finnhub.io/api/news?id=f9d178c84ba0b4f360c3a2d5796afdc6a285bb758a58127e98925481a05e046d",
                "image": "",
                "source": "Benzinga",
                "related": "MDT",
                "summary": "TD Cowen  analyst Joshua Jennings   maintains Medtronic (NYSE:MDT) with a Buy and lowers the price target from $119 to $100.",
                "category": "company",
                "datetime": 1783677292,
                "headline": "TD Cowen Maintains Buy on Medtronic, Lowers Price Target to $100"
              },
              {
                "id": 140860227,
                "url": "https://finnhub.io/api/news?id=1bb96a3ccfe31cbf811f2aa959e5560de4117b3254798ddffde505d6436dc7d9",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2254793533/image_2254793533.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MDT",
                "summary": "Medtronic delivered $36.4B in revenue, the strongest growth in a decade, led by Cardiovascular and ablation solutions. Learn why MDT stock is a buy.",
                "category": "company",
                "datetime": 1783665144,
                "headline": "Medtronic: Guidance Built To Be Beaten - Buy"
              },
              {
                "id": 140857904,
                "url": "https://finnhub.io/api/news?id=4174d960b7f8c4a4b30edb1e4d248adca90adfa7b08fb46596a87b37b82bd674",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (MDT) is in focus after the US Food and Drug Administration published an enforcement report on a voluntary Class II recall of the Octopus 4 Tissue Stabilizer, citing an assembly issue affecting 590 units. See our latest analysis for Medtronic. At a share price of $82.39, Medtronic has had a mixed run, with the 1-day share price return of 0.46% contrasting with a year to date share price decline of 14.22% and a 5 year total shareholder return that is down 23.13%. This suggests...",
                "category": "company",
                "datetime": 1783653776,
                "headline": "Medtronic (MDT) Could Be 9% Undervalued On Recall News"
              },
              {
                "id": 140855858,
                "url": "https://finnhub.io/api/news?id=34d848e61127c39cc8a2096258a29d8000a274bfddc5ad5253f0961ce4593068",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic issued a voluntary global recall of its Octopus 4 Tissue Stabilizer after identifying an assembly issue during manufacturing. The recall covers a widely distributed cardiac surgery device used to stabilize tissue during procedures. The company is working with customers and regulators to remove affected product from use and investigate the manufacturing issue. For investors tracking Medtronic (NYSE:MDT), the recall comes as the stock trades around $82.01, with a value score of 4...",
                "category": "company",
                "datetime": 1783631687,
                "headline": "Medtronic (MDT) Recalls Octopus 4 Tissue Stabilizer After Manufacturing Assembly Issue"
              },
              {
                "id": 140854817,
                "url": "https://finnhub.io/api/news?id=0e5f69397fac83deda6d8bf66036466817b0cd283812b3bf8dda143b7256559d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic stock sits in an interesting middle ground, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a price that is roughly in line with the market, while the earnings multiples still suggest the shares lean toward the cheaper side after a difficult five year stretch. Over the past five years, Medtronic has delivered a decline of 24.9% including dividends, which means the stock has not rewarded long term holders despite its recent news flow and portfolio...",
                "category": "company",
                "datetime": 1783624308,
                "headline": "Medtronic (MDT) Stock Could Be 6% Undervalued On Fresh Deal News"
              },
              {
                "id": 140852295,
                "url": "https://finnhub.io/api/news?id=33fcda0f34cf71ba33bf1f5fd26dd4a8a1bface677ea2b2eba3a0ad455a486ba",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The orthopedic surgical robots market presents growth opportunities in AI integration, digital workflows, and minimally invasive procedures. Key areas include knee, hip, spine, and shoulder robotics, with significant regional potential in Asia-Pacific and North America. Focus areas include innovation, ESG, and training. Orthopedic Surgical Robots Market Orthopedic Surgical Robots Market Dublin, July 09, 2026 (GLOBE NEWSWIRE) -- The \"Global Orthopedic Surgical Robots Market\" has been added to Res",
                "category": "company",
                "datetime": 1783608240,
                "headline": "Global Orthopedic Surgical Robots Market Report Published — Profiles Stryker, Zimmer Biomet, DePuy Synthes, and Medtronic"
              },
              {
                "id": 140852299,
                "url": "https://finnhub.io/api/news?id=f510a7398e32584659099b560b5a3e238c433e7fa50b01dfea03c0f42e65489d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Opportunities in the medical ventilators market include the rising demand for advanced respiratory care, driven by healthcare prioritization, technological advancements, and increased adoption of AI. Growth potential exists across product types, ventilation methods, and regions globally, offering innovation and expansion prospects. Medical Ventilators Market Medical Ventilators Market Dublin, July 09, 2026 (GLOBE NEWSWIRE) -- The \"Medical Ventilators Market\" has been added to ResearchAndMarkets.",
                "category": "company",
                "datetime": 1783608180,
                "headline": "Global Medical Ventilators Market Report 2025-2030 Just Released; Comprehensive Profiles of Getinge, Drägerwerk, Philips, Medtronic, and ResMed"
              },
              {
                "id": 140852127,
                "url": "https://finnhub.io/api/news?id=3dc0ae22f59ecc076a1a15b91bdc68fa65b5f68b674058d014aa38fddece5920",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "If you hold shares in this medical device maker, you are already carrying the full weight of a sizable potential swing that the market is pricing for the year ahead.",
                "category": "company",
                "datetime": 1783604422,
                "headline": "The Wide Chasm Priced Into Boston Scientific Stock"
              },
              {
                "id": 140850835,
                "url": "https://finnhub.io/api/news?id=9966738aa03e2c1d7bf64189594dd665e4ed1896a9b982f1abb0e878f0e60f2b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The options market has priced a sizable range of outcomes for the surgical robotics leader, and if you hold the shares, you are already carrying that full exposure.",
                "category": "company",
                "datetime": 1783603762,
                "headline": "Just How Much Risk Is Built Into ISRG Stock?"
              },
              {
                "id": 140851034,
                "url": "https://finnhub.io/api/news?id=fbd429437af6da7e6d6db2fb997ec0ff61cd8b8ed5974cd91a1292b6aa3b7500",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Retia Medical, the developer of cardiovascular intelligence software that transforms routine physiologic monitoring data into actionable clinical insight, today announced the appointment of Christopher Benassi, former Vice President, Connected Care Group at Baxter International, to its Strategic Advisory Board.",
                "category": "company",
                "datetime": 1783601580,
                "headline": "Retia Medical Appoints Christopher Benassi to Strategic Advisory Board"
              },
              {
                "id": 140852128,
                "url": "https://finnhub.io/api/news?id=0d8d5355ebff870c994dea78b71564f062bb6a51ab8e04cbf1a91b3ad27b8cd6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Johnson & Johnson expects U.S. physicians to perform the first procedures with the device this summer as it starts a phased commercial rollout.",
                "category": "company",
                "datetime": 1783591200,
                "headline": "J&J wins FDA approval for dual-energy ablation catheter"
              },
              {
                "id": 140850290,
                "url": "https://finnhub.io/api/news?id=e8dd48ed2dce018874fe078d00574ca010dffc8c88bc10a8d949fd09b6a4f3fe",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2228279012/image_2228279012.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MDT",
                "summary": "Medtronic is a dividend aristocrat with a near-decade high yield, making it an attractive long-term income opportunity.",
                "category": "company",
                "datetime": 1783585943,
                "headline": "Medtronic: A Near Decade High Dividend For This Aristocrat"
              },
              {
                "id": 140843377,
                "url": "https://finnhub.io/api/news?id=0c81e90fd0177693e04c6f597f3094721aad21cf484f4f5e2f07a9365658f254",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "If you hold shares in this surgical robotics leader, you are already carrying a sizable two-sided risk, whether you trade options or not.",
                "category": "company",
                "datetime": 1783528899,
                "headline": "Just How Wide Is The Path Ahead For Intuitive Surgical Stock?"
              },
              {
                "id": 140840581,
                "url": "https://finnhub.io/api/news?id=97e341c2e51d166601008fe13338b21e416c3cf92f2f610cc98c7bdfa93190d9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Neuspera Medical today highlighted that the Centers for Medicare & Medicaid Services (CMS) has confirmed the assignment of the billing code for the Neuspera Sacral Neuromodulation System (SNM) to payment level APC 5464 in the proposed CY 2027 Outpatient Prospective Payment System Rule.1 The assignment provides the externally powered integrated SNM (iSNM) system the same Medicare payment as all other neuromodulation implantable therapies for urinary urge incontinence. The rule also increases the",
                "category": "company",
                "datetime": 1783515840,
                "headline": "Neuspera Integrated Sacral Neuromodulation System (iSNM) to Receive Same Medicare Payment as Legacy Implantable SNM Devices Under Proposed 2027 CMS Rule"
              },
              {
                "id": 140839793,
                "url": "https://finnhub.io/api/news?id=303ee684ee433beba364a488812c644cbdf27564c78a5b59a237e3643f317e29",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2172700619/image_2172700619.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MDT",
                "summary": "Stryker stock looks undervalued with a 13% discount to fair value, a strong EPS growth outlook, and dividend potential. Click for more on SYK stock.",
                "category": "company",
                "datetime": 1783497600,
                "headline": "Stryker: Medtech On Sale, Benefiting From Industry Growth"
              },
              {
                "id": 140835477,
                "url": "https://finnhub.io/api/news?id=b03613ad52a2bf852782ae88316b0d4f5ca9f28d287f041d33fb5612ca8121d0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Finding stocks with generous dividends isn’t easy these days, and with packaged food giant Conagra recently getting demoted from the S&P 500, Pfizer is now the highest yielding stock in the benchmark index.  The drug company, which has made quarterly payouts more than 80 straight years, is certain to get a lot of attention from dividend hunters.  Pfizer’s high yield reflects investors’ trepidation over the stock.",
                "category": "company",
                "datetime": 1783452780,
                "headline": "2 Healthcare Stocks to Buy for Their Dividends—and Why Pfizer Isn’t One of Them"
              },
              {
                "id": 140830065,
                "url": "https://finnhub.io/api/news?id=3c61c162eeb4a4ff55bbbf7eb416d76bd56a1411992abae065eed559761e61eb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Generate an immediate income that you keep regardless, plus the opportunity to buy the stock cheaper should its price fall far enough.",
                "category": "company",
                "datetime": 1783430548,
                "headline": "How To Target A 10% Yield While Catching The BSX Stock Knife?"
              },
              {
                "id": 140821047,
                "url": "https://finnhub.io/api/news?id=2912828987debfe482d154cb8869250ceca30533455825d752a5f8b801edaad6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "While investors fixate on slowing elective surgeries, a powerful, non-obvious growth engine is accelerating inside the company's U.S. business.",
                "category": "company",
                "datetime": 1783351875,
                "headline": "Intuitive Surgical Stock Looks Weighed Down. Its After-Hours Growth Says Otherwise."
              },
              {
                "id": 140822462,
                "url": "https://finnhub.io/api/news?id=fb503b298eddbe55fa669632c0bf8202960ac03b9180070af394c3342a8ad8b7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "JNJ's Q2 MedTech results will test whether cardiovascular, surgery and vision strength can offset ongoing China VBP headwinds and sustain growth.",
                "category": "company",
                "datetime": 1783349880,
                "headline": "J&J's MedTech Segment Eyes Another Strong Quarter in Q2"
              },
              {
                "id": 140824662,
                "url": "https://finnhub.io/api/news?id=12abad61e4423bb1ad1162cf5957cbef39b6a46ed3685ffafe3f3eaa53a11e19",
                "image": "",
                "source": "Benzinga",
                "related": "MDT",
                "summary": "Evercore ISI Group  analyst Vijay Kumar   maintains Medtronic (NYSE:MDT) with a Outperform and lowers the price target from $106 to $105.",
                "category": "company",
                "datetime": 1783341031,
                "headline": "Evercore ISI Group Maintains Outperform on Medtronic, Lowers Price Target to $105"
              },
              {
                "id": 140821122,
                "url": "https://finnhub.io/api/news?id=bc1a01e4a3153aeaa577fecd21bc76829a5c301b0d3227ab5365e40dcf8bb30d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Boston Scientific, Medtronic and Stryker were among the companies to ink deals to move into markets that are expanding quickly.",
                "category": "company",
                "datetime": 1783332000,
                "headline": "Top 10 medtech deals in the first half of 2026"
              },
              {
                "id": 140801169,
                "url": "https://finnhub.io/api/news?id=2d9d0ed12ff54560a002f19794ba21d0b426f9d453da7cfbff7734320f087a19",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1783092604,
                "headline": "Why Is Medtronic (MDT) Up 1.5% Since Last Earnings Report?"
              },
              {
                "id": 140799660,
                "url": "https://finnhub.io/api/news?id=40ad03261eb6b938b097c4a9e29e334c204ecc7d70c05ea0210968033f6edfdb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (NYSE:MDT) has notified individuals affected by a cyberattack, outlining data security steps and offering identity protection support. The company reports no impact on patient safety or core operations related to this incident. Separately, Medtronic has expanded its partnership with Retia Medical to distribute advanced cardiac output monitoring technology more widely. The extended collaboration targets use in high risk surgeries and critical care settings to support clinicians...",
                "category": "company",
                "datetime": 1783084633,
                "headline": "Medtronic (MDT) Alerts Cyberattack Victims While Expanding Retia Cardiac Monitoring Partnership"
              },
              {
                "id": 140794039,
                "url": "https://finnhub.io/api/news?id=8831e57c447685f7d89edb07b4c239f2b6fa697dd0711d22279e85d63efc7d36",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "While a guidance cut has reset expectations, several core Boston Scientific franchises are accelerating. The Neuromodulation and Interventional Oncology businesses both posted organic sales growth of 15% last quarter. This internal momentum in high-value categories contrasts sharply with the new, more cautious company-wide outlook.",
                "category": "company",
                "datetime": 1783013922,
                "headline": "What Could Push BSX Stock Higher From Here?"
              },
              {
                "id": 140792959,
                "url": "https://finnhub.io/api/news?id=ee6da6462659dfa08361afe62be1aecd7ac76b797f01f38b6a14f5d8d0d35fbe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The healthcare giant raised its outlook for the year, yet the market is holding back its reward, creating a tense waiting game for investors.",
                "category": "company",
                "datetime": 1783013373,
                "headline": "JNJ Stock Management Sees A Breakout, The Market Sees A Standoff"
              },
              {
                "id": 140791520,
                "url": "https://finnhub.io/api/news?id=bc0f78bdb4c3f98c0fb124464b8679ceea1ccd73cc83edad92ec57bb25675111",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The medtech giant said it currently has no evidence that the accessed data has been posted to the internet.",
                "category": "company",
                "datetime": 1782992700,
                "headline": "Medtronic starts to notify people affected by cyberattack"
              },
              {
                "id": 140784805,
                "url": "https://finnhub.io/api/news?id=4d38d5f6dab422dbbe1e36c6696b53e4003879172f50e309ff938805e7330fe3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic plc (NYSE:MDT) is one of the best dividend aristocrat stocks to buy now. On June 5, Cardiovascular intelligence software company Retia Medical expanded its commercial relationship with Medtronic plc (NYSE:MDT) to include the distribution of Argos Cardiac Output Monitor. Medtronic is to help Retia expand into new markets and bring its hemodynamic monitoring technology […]",
                "category": "company",
                "datetime": 1782935610,
                "headline": "Medtronic plc (MDT) & Retia Expand Partnership to Target High-Risk Surgical and Critically ill Patients"
              },
              {
                "id": 140776281,
                "url": "https://finnhub.io/api/news?id=0ff248ca98aab4cacc7e5e1ce307026c372dfe4fdf6118158852b363b398d286",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (MDT) reached $78.23 at the closing of the latest trading day, reflecting a -3.34% change compared to its last close.",
                "category": "company",
                "datetime": 1782856204,
                "headline": "Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know"
              },
              {
                "id": 140775242,
                "url": "https://finnhub.io/api/news?id=02b91b29d4d6866e764fad5d9b5d883e4c856174563540aa0f7ce0aaf8483c13",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "The healthcare giant is making waves, but its true value for investors lies in how little it moves with the market.",
                "category": "company",
                "datetime": 1782851051,
                "headline": "Why Is JNJ Stock Defying The Market’s Daily Mood Swings?"
              },
              {
                "id": 140775342,
                "url": "https://finnhub.io/api/news?id=2f0404af8c7feaca25285faa58942ea898598b64e4631a25ce777e18f1fc76de",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "A report by the island nation’s fiscal watchdog group said that corporate tax revenue is “not a reliable source to fund permanent spending commitments.”",
                "category": "company",
                "datetime": 1782831420,
                "headline": "Ireland would run deficit without foreign income: Report"
              },
              {
                "id": 140766858,
                "url": "https://finnhub.io/api/news?id=13d25dfa75f0d8872880e7edde1c3fc11589a4e156ed3149174f4b0e5d323eae",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Is MDT a good stock to buy? We came across a bullish thesis on Medtronic plc on TheDividendPrince’s Substack. In this article, we will summarize the bulls’ thesis on MDT. Medtronic plc’s share was trading at $80.98 as of June 26th. MDT’s trailing and forward P/E were 21.71 and 13.59 respectively according to Yahoo Finance. Medtronic plc […]",
                "category": "company",
                "datetime": 1782767338,
                "headline": "Is Medtronic plc (MDT) A Good Stock To Buy Now?"
              },
              {
                "id": 140765526,
                "url": "https://finnhub.io/api/news?id=b3425c7e4c6406cbfb00794a39317cbeec5fe8b109f6c5372505b86cc540e74f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Globus Medical or Medtronic? See why Globus Medical's stronger growth, innovation and analyst upside may give it the edge despite a richer valuation.",
                "category": "company",
                "datetime": 1782754620,
                "headline": "GMED vs. MDT: Which Medical Stock Has More Upside Potential?"
              },
              {
                "id": 140762661,
                "url": "https://finnhub.io/api/news?id=436a621c27ef4c5a4c8af1390e6ab512fb77305db81ffffa5d81207c83cb97fb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "ABT's Medical Devices unit builds on strong growth with new diabetes, heart rhythm and electrophysiology advances ahead of Q2 2026.",
                "category": "company",
                "datetime": 1782739200,
                "headline": "How Abbott's Largest Segment Is Preparing for the Next Growth Phase"
              },
              {
                "id": 140764120,
                "url": "https://finnhub.io/api/news?id=15115c8ddf386bc50ddc3fb9d01795b6c1cbd80a889b327a585df6d4ea69da48",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Edwards Lifesciences is expected to introduce the new device to surgical heart valve customers this year in a “measured, targeted rollout,” one analyst said.",
                "category": "company",
                "datetime": 1782731798,
                "headline": "Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic"
              },
              {
                "id": 140761351,
                "url": "https://finnhub.io/api/news?id=3435bbc3511e9ce227f612795737829f8bb6e00777338a3388d5b09824ad916d",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2282777261/image_2282777261.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MDT",
                "summary": "Roundhill Memory ETF (DRAM) targets DRAM/NAND/HBM leaders like SK Hynix, Samsung & Micron; July 10 SKHY listing may boost momentum—learn more.",
                "category": "company",
                "datetime": 1782724799,
                "headline": "DRAM: Stealth Rallies And The Plenum Of Memory"
              },
              {
                "id": 140759247,
                "url": "https://finnhub.io/api/news?id=579c3d4836210e6d763f17334c151c09f4dd9de2b1e9a2d9b890111d14249a78",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MDT",
                "summary": "Medtronic (NYSE:MDT) is one of the best long term stocks to buy according to hedge funds. On June 8, Medtronic received FDA 510(k) clearance for its Nellcor pulse oximetry system featuring the new Nell-EQ intelligent processor. This technology is engineered to provide more consistent and reliable pulse rate and oxygen saturation monitoring across various patient […]",
                "category": "company",
                "datetime": 1782711028,
                "headline": "Here is Why Medtronic (MDT) is One of the Best Long Term Stocks to Buy According to Hedge Funds"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 1,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.3,
            "source_article_count": 111,
            "discarded_article_count": 90
          },
          "sentimentPoints": 3
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 24.4,
        "grade": "優秀",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 3,
          "vcpPoints": 1.4,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.4,
            "vcp_reason": "站上MA50；升放量(近10日2日)；收盤突破20日高位；Ready=N；Confirm=Y",
            "vcp_metrics": {
              "up_days": 6,
              "vol_ref": 8472156.666666666,
              "down_days": 3,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 6923060,
              "avg_vol_20": 7410770,
              "avg_vol_30": 8472156.666666666,
              "range_pct_10": 0.07101749539594845,
              "range_pct_20": 0.09035451197053401,
              "range_pct_30": 0.09633977900552476,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 2,
              "breakout_20d_ok": true,
              "vol_ratio_10_30": 0.817154388473301,
              "dist_to_20d_high": -0.010350040702407264,
              "down_shrink_days": 2,
              "breakout_level_20d": 85.99,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 0.7371565113500607
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.8,
          "rsiKdjPoints": 4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 1,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 1,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.8,
            "details": {
              "atrPct": 2.67944290976059,
              "turnoverUsdM": 1134.4402046399998,
              "liquidityPoints": 0.8,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.8,
          "stopLevels": {
            "symbol": "US.MDT",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 82.2242,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 3,
              "macd_score": 3,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.7,
            "stop_loss_percent": 5.4,
            "take_profit_price": 94.9035,
            "target_multiplier": 2.2,
            "technical_strength": 2.35,
            "take_profit_percent": 9.2
          },
          "positionPoints": 1.8,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.7167747755487774,
          "stopLossPercent": 5.35888581952118,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 71.43,
    "atr": {
      "atr": 2.3279,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.68
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 236.51
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.1939
    },
    "kdj": {
      "d": 63.91,
      "j": 82.11,
      "k": 69.97,
      "rule": "Cursor_18.24 K/D cross",
      "score": 6,
      "signal": "強金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 63.2
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 8,
      "trend": "資金入貨",
      "value": 2693853,
      "recentSlope": 2557435.3,
      "previousSlope": 1811040
    },
    "rsi": 63.89,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 10,
      "trend": "上升",
      "value": 78.97,
      "position": "SAR由上轉下+趨勢強",
      "distancePct": 9.1,
      "previousTrend": "下降"
    },
    "ma50": 80.2802,
    "macd": {
      "macd": 1.085941004270083,
      "trend": "強烈看漲",
      "signal": 0.8426848935332003,
      "histogram": 0.2432561107368827
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 82.6901,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 9
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.71,
      "score": 6,
      "avgVolume": 7633783,
      "currentVolume": 13057553
    },
    "derived": {
      "ma20": 82.4865,
      "ma50": 80.2802,
      "prevClose": 84.22,
      "avgVolume10": 7378875,
      "avgVolume20": 7633783,
      "changePercent": 3.16,
      "avgVolumeForScore": 7633783
    },
    "ma_cross": {
      "ma20": 82.4865,
      "ma50": 80.2802,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 82.189,
      "prevMa50": 80.082,
      "spreadPct": 2.75,
      "isVolumeBreakout": true
    },
    "bollinger": {
      "lower": 78.6179,
      "upper": 86.3551,
      "position": "上半部"
    },
    "rsi_short": 78.09,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.71
    }
  }
}

{
  "close": 86.88,
  "volume": 13057553,
  "changePercent": 3.16
}